Header Ads Widget

Responsive Advertisement

TRENDING

6/recent/ticker-posts

Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19. 

from Zee News :India National https://ift.tt/3yhEwmL

Post a Comment

0 Comments